849675-46-3

Basic information

• Product Name: Benzenamine, 2-[2-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-2 H-tetrazol-5-yl]-4,5-dimethoxy-
• CAS NO: 849675-46-3
• Molecular Formula: C28H32N6O4
• Molecular Weight: 516.6
• Mol File: 849675-46-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2-[2-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-2 H-tetrazol-5-yl]-4,5-dimethoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2-[2-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-2 H-tetrazol-5-yl]-4,5-dimethoxy-(849675-46-3)
• EPA Substance Registry System: Benzenamine, 2-[2-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-2 H-tetrazol-5-yl]-4,5-dimethoxy-(849675-46-3)

Safety Data

• Hazardous Substances Data: 849675-46-3(Hazardous Substances Data)

Upstream product

• 2328-12-3 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline monohydrochloride 
• 20357-25-9 6-nitroveratraldehyde 
• 5339-26-4 (4-nitrophenyl)ethyl bromide 
• 82925-02-8 4-<2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolyl)ethyl>benzenamine 
• 82925-01-7 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-(4-nitrophenyl)ethyl]-isoquinoline 

Downstream Products

• 849675-66-7 encequidar 

Relevant articles and documents

Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor

Many chemotherapeutics, such as paclitaxel, are administered intravenously as they suffer from poor oral bioavailability, partly because of efflux mechanism of P-glycoprotein in the intestinal epithelium. To date, no drug has been approved by the U.S. Foo

METHOD FOR PREPARING TETRAZOLE METHANESULFONIC ACID SALTS, AND NOVEL COMPOUND USED IN SAME

According to the present invention, a method for preparing tetrazole methanesulfonic acid salts comprises an acylation reaction using a novel 4-iodine-4H-chromene-2-carbothionic acid S-benzothiazole-2-yl ester. The method of the present invention can shor